Neuron23 Inc.

Parkinson’s disease

Research activity is centered on Parkinson’s disease, with attention to both early Parkinson disease and idiopathic Parkinson disease. The sponsor’s clinical interest extends across Parkinson and parkinsonism-related disease presentations, reflecting a focused neurology portfolio.

  • Early Parkinson disease
  • Idiopathic Parkinson disease
  • Parkinson’s disease

The trial landscape indicates a specific therapeutic emphasis on disease-modifying approaches for movement disorders associated with Parkinsonian syndromes.

Genetically defined neurology

The sponsor’s research includes LRRK2-driven Parkinson’s disease, highlighting an interest in genetically characterized subgroups within neurodegenerative disease. This focus aligns with companion diagnostic-positive populations and biomarker-defined patient selection in neurology.

  • LRRK2-driven Parkinson’s disease
  • Companion diagnostic-positive
  • Biomarker-defined patient groups

Clinical activity in this area points to precision medicine approaches within central nervous system disorders.

Neurodegeneration and central nervous system disease

The funded research sits within the broader field of neurodegenerative disorders, with a particular concentration on central nervous system pathology affecting motor function. The therapeutic interest is aligned with neurological conditions that progress over time and require targeted intervention.

  • Neurodegenerative disorders
  • Central nervous system disease
  • Motor system dysfunction

This area reflects a clinical research focus on neurological disease mechanisms relevant to Parkinsonian syndromes.

Clinical development in neurology

Clinical research activity is organized around a small but concentrated neurology program involving multiple collaborating sites across several countries. The sponsor’s work is directed toward therapeutic development in Parkinson’s disease populations, with an emphasis on identifying and treating patients with defined biological features.

  • Neurology
  • Parkinson’s disease populations
  • Biologically defined subtypes

The research profile is closely tied to clinical investigation in movement disorder medicine.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Safety and Effectiveness of NEU-411 for Patients with Early Parkinson’s Disease

    Not yet recruiting

    Italy Poland Spain